jobs.jnj.com/en/jobs/

✕

Internet Explorer is no longer supported by this website.

For optimal browsing we recommend using Chrome, Firefox or Safari.

Share

Hemolytic Disease of the Fetus and Newborn

ON NOW What Are Autoantibodies?

Innovation

What Are Autoantibodies?

What Are Autoantibodies?

More than 200 million people worldwide are living with an autoantibody disease, which occurs when the body attacks its own cells, tissues and proteins.
ON NOW "I Had a Condition That Threatened My Chances of Having Healthy Children"

Personal Stories

"I Had a Condition That Threatened My Chances of Having Healthy Children"

"I Had a Condition That Threatened My Chances of Having Healthy Children"

For Pregnancy and Infant Loss Awareness Month, learn how one woman advocated for herself and fought to complete her family after she was diagnosed with hemolytic disease of the fetus and newborn—and why Johnson & Johnson is committed to finding a better treatment for this rare and deadly blood disorder.
ON NOW What to Know About HDFN—a Serious Blood Disorder in Babies—Including a Possible New Treatment

Innovation

What to Know About HDFN—a Serious Blood Disorder in Babies—Including a Possible New Treatment

What to Know About HDFN—a Serious Blood Disorder in Babies—Including a Possible New Treatment

Severe cases of hemolytic disease of the fetus and newborn can be deadly in infants. That's why Johnson & Johnson is passionate about investigating a promising option for treating the disorder.